Researcher from Heart Rhythm Management Centre Reports Details of New Studies and Findings in the Area of Atrial Fibrillation (Prevention of thromboembolic events in atrial fibrillation patients with persistent leaks following the watchman...).

A recent study from the Heart Rhythm Management Centre focused on atrial fibrillation patients with persistent leaks following the Watchman device implantation. The research compared the effectiveness of half-dose non-vitamin K oral anticoagulants (HD-NOAC) versus antiplatelet therapy (APT) in preventing thromboembolic events. Results showed that HD-NOAC was associated with a significantly lower rate of thromboembolic events compared to APT, but discontinuation of HD-NOAC increased the risk of stroke. This study provides valuable insights into the management of atrial fibrillation patients with post-Watchman leaks. [Extracted from the article]